About burning rock biotech ltd. - BNR
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
BNR At a Glance
Burning Rock Biotech Ltd.
No 5 Xingdao Ring Road North
Guangzhou, Guangdong 510005
| Phone | 86-20-34037871 | Revenue | 75.06M | |
| Industry | Medical/Nursing Services | Net Income | -7,699,297.47 | |
| Sector | Health Services | 2025 Sales Growth | 4.725% | |
| Fiscal Year-end | 12 / 2026 | Employees | 667 | |
| View SEC Filings |
BNR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.854 |
| Price to Book Ratio | 2.767 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -32.924 |
| Enterprise Value to Sales | 2.019 |
| Total Debt to Enterprise Value | 0.041 |
BNR Efficiency
| Revenue/Employee | 112,534.377 |
| Income Per Employee | -11,543.175 |
| Receivables Turnover | 2.721 |
| Total Asset Turnover | 0.629 |
BNR Liquidity
| Current Ratio | 2.956 |
| Quick Ratio | 2.76 |
| Cash Ratio | 1.948 |
BNR Profitability
| Gross Margin | 74.673 |
| Operating Margin | -10.165 |
| Pretax Margin | -9.969 |
| Net Margin | -10.257 |
| Return on Assets | -6.452 |
| Return on Equity | -9.86 |
| Return on Total Capital | -9.302 |
| Return on Invested Capital | -9.406 |
BNR Capital Structure
| Total Debt to Total Equity | 8.056 |
| Total Debt to Total Capital | 7.455 |
| Total Debt to Total Assets | 5.256 |
| Long-Term Debt to Equity | 4.887 |
| Long-Term Debt to Total Capital | 4.523 |